- Previous Close
679.25 - Open
681.90 - Bid --
- Ask --
- Day's Range
656.70 - 681.90 - 52 Week Range
598.60 - 849.00 - Volume
95,562 - Avg. Volume
758,556 - Market Cap (intraday)
81.547B - Beta (5Y Monthly) 0.79
- PE Ratio (TTM)
105.73 - EPS (TTM)
6.34 - Earnings Date Nov 12, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
875.99
MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, comprising medicines, vitamins, medical devices, and test kits; and offers consumer goods, such as home and personal care products, including toiletries, baby care products, soaps and detergents, and sanitizers. The company also provides wholesale cash and carry; diagnostic, pathological, and laboratory testing services, as well as engages in the contract manufacturing of private label pharmaceuticals. It operates stores in Telangana, Andhra Pradesh, Karnataka, Tamil Nadu, West Bengal, Maharashtra, Orissa, Madhya Pradesh, Chhattisgarh, Kerala, and Puducherry, as well as online platform. The company was incorporated in 2006 and is based in Hyderabad, India.
www.medplusindia.com23,415
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: MEDPLUS.NS
View More
Performance Overview: MEDPLUS.NS
Trailing total returns as of 11/4/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MEDPLUS.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MEDPLUS.NS
View MoreValuation Measures
Market Cap
81.12B
Enterprise Value
89.57B
Trailing P/E
105.35
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.39
Price/Book (mrq)
5.05
Enterprise Value/Revenue
1.61
Enterprise Value/EBITDA
22.73
Financial Highlights
Profitability and Income Statement
Profit Margin
1.30%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
58.29B
Net Income Avi to Common (ttm)
760.5M
Diluted EPS (ttm)
6.34
Balance Sheet and Cash Flow
Total Cash (mrq)
1.74B
Total Debt/Equity (mrq)
64.00%
Levered Free Cash Flow (ttm)
--
Research Analysis: MEDPLUS.NS
View MoreCompany Insights: MEDPLUS.NS
MEDPLUS.NS does not have Company Insights